We are safely reopening the clinical trial of a FDA approved topical botanical drug to reduce painful sex for postmenopausal women. Clinical sites are currently available in New York City and Rockland County.As the health and peace-of-mind of our patients are of the utmost importance, our new protocols reflect strict safety measures to ensure a seamless transition. Each patient is pre-screened over the phone and scheduled to be seen one at a time with little waiting time. All staff will be wearing masks and all patients must also wear a face covering. We are also ensuring proper cleaning procedures between visits to keep our practice clean and safe throughout.
We are now extending the invitation to the clinical trial to include women who are also using estrogens or DHEA in any form. Whether or not you are using estrogens, DHEA, Tamoxifen and/or aromatase inhibitors you are welcome to apply.
If you or someone you know may benefit from this study, we encourage you to apply or forward on this announcement by July 1st, 2020. All participants will be compensated for their time.
Janis L. Enzenbacher, MD
We are conducting this clinical trial because many women need a safe, effective topical treatment for sexual pain without the use of hormones.
If you qualify you may receive at no cost:
- A FDA approved topical botanical drug or placebo
- Study-related care from a local doctor in NYC or Rockland County
- Compensation for time
You may be eligible if you:
- Are postmenopausal 70 years or younger
- Experiencing sexual pain
- Live in the NY Metro area with regular email access
- Other inclusion criteria may apply